FDA approves combination meningococcal vaccine

“The U.S. Food and Drug Administration approved British drugmaker GSK’s combination vaccine to protect against meningococcal infection for use in people aged 10 through 25 years, the company said on Saturday. Meningococcal infections, caused by bacteria called...